Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Q BioMed Inc QBIO

Healthcare Biotechnology
Q BioMed Inc. is a biotech acceleration and commercial stage company. The Company is focused on licensing and acquiring undervalued biomedical assets in the healthcare sector. The Company’s pipeline products include Strontium89, QBM-001, Uttroside-B, and MAN 01. Strontium89 treats pain from bone metastases caused by multiple primary tumors. Strontium Chloride Sr-89 Injection, USP is indicated... see more

Recent & Breaking News (GREY:QBIO)

OTCQX and OTCQB Companies to Present at 2016 Marcum MicroCap Conference

PR Newswire May 31, 2016

Q BioMed Inc. to Present at the Fifth Annual Marcum Microcap Conference in New York

PR Newswire May 26, 2016

Mannin Research to Participate at ARVO 2016 Meeting

PR Newswire May 2, 2016

Media Alert - Q BioMed Inc CEO Pens Management Piece Featured in Life Science Leader

PR Newswire April 28, 2016

Q BioMed Inc. to Present at the Global Chinese Financial Forum on April 30, 2016

PR Newswire April 26, 2016

Mannin Research to Present Glaucoma Therapeutics Treatment at MedCity INVEST Chicago April 12-13 2016

PR Newswire April 12, 2016

Q BioMed Inc Featured in April Issue of PharmaVOICE Magazine

PR Newswire April 5, 2016

StockNewsNow.com Publishes New SNNLive Video Interview With Q BioMed Inc.

Marketwired March 24, 2016

President of Q BioMed Inc. Expands on Corporate Update in Q&A

Marketwired March 21, 2016

Q BioMed Inc. Congratulates Mannin Research on Selection to the Chicago-Canada Mentorship Program (C2MP) and Inaugural Meeting

PR Newswire March 17, 2016

Q BioMed Inc. CEO Provides Corporate Overview in an Interview With Scrip Intelligence

PR Newswire February 29, 2016

Q BioMed Inc. To Present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at the Ritz in South Beach on Feb. 22, 2016

Press Releases February 16, 2016

Q BioMed Inc. Provides a Corporate Update

PR Newswire February 4, 2016

Q BioMed Inc. to Present at Biotech Showcase((TM)) 2016

PR Newswire January 5, 2016

Q BioMed Inc. Appoints Industry Executive to Management Team

PR Newswire December 16, 2015

Q BioMed Inc. Uplisted to OTCQB Market

PR Newswire November 13, 2015

Q BioMed Inc. Strengthens Advisory Board

PR Newswire November 12, 2015

Q BioMed Inc. and Mannin Research Inc Sign Definitive License Agreement

PR Newswire October 30, 2015

Q BioMed Inc. Enters into Partnership with the Strategic and Scientific Advisory Firm Wombat Capital, Ltd.

PR Newswire October 13, 2015

Q BioMed Inc. CEO Denis Corin Interviewed on Wall St. Analyzer

PR Newswire September 24, 2015